Orthocell Limited (OCC) 2019年年度报告「ASX」.pdf

1、Appendix 4E Preliminary final Report+See chapter 19 for defined terms30/06/2016 Appendix 4E Page 1 Rules 4.3A Appendix 4E F Final reportName of entity ORTHOCELL LIMITED ABN or equivalent company reference Financial year ended(current period)57 118 897 135 30 June 2019 For announcement to the marketC

2、urrent year reported amount$Change up/(down)from previous year$Change up/(down)from previous year%Revenues from product sales 945,657 326,478 53%Other revenues from continuing operations 293,714 10,211 4%Total revenues from continuing operations 1,239,371 336,689 37%Loss from ordinary activities aft

3、er tax attributable to members(5,852,214)95,100 2%Net loss for the period attributable to members(5,852,214)95,100 2%Dividends(distributions)Amount per security Franked amount per security Interim dividend Nil-Final dividend Nil-Previous corresponding period Nil-+Record date for determining entitlem

4、ents to the dividend,(in the case of a trust,distribution)N/A The above results should be read in conjunction with the notes and commentary contained in this report.Appendix 4E Final Report+See chapter 19 for defined terms30/06/2016 Appendix 4E Page 2 Annual meeting Final report only)The annual meet

5、ing will be held as follows:Place Building 191 Murdoch University Corner of Campus Drive&Discovery Way Murdoch WA 6150 Date On or before 30 November 2019 Time To be advised Approximate date the+annual report will be available On or before 30 October 2019 Compliance statement 1 This report has been p

6、repared in accordance with AASB Standards,other AASB authoritative pronouncements and Urgent Issues Group Consensus Views or other standards acceptable to ASX.2 This report,and the+accounts upon which the report is based(if separate),use the same accounting policies.3 This report does give a true an